Andy Gray BPharm, MSc (Pharm), FPS, FFIP is a pharmacist whose research interests include policy analysis (in particular, the development and implementation of National Medicines Policies), rational medicines use and the application of antiretroviral therapy in resource-constrained settings.
He is a Senior Lecturer in the Division of Pharmacology, Discipline of Pharmaceutical Sciences, School of Health Sciences, University of KwaZulu-Natal, Durban, South Africa. The Discipline is designated as a WHO Collaborating Centre on Pharmaceutical Policy and Evidence-Based Practice. He is also an Honorary Senior Scientist, Consultant Pharmacist for the Centre for the AIDS Programme of Research in South Africa (CAPRISA), and non-executive Director of JEMBI Health Systems (NPC). Andy is a Visiting Fellow in the Faculty of Pharmacy, Rhodes University, Makhanda.
Andy is a Fellow and Honorary Life Member of the Pharmaceutical Society of South Africa (PSSA) and a Fellow of the International Pharmaceutical Federation (FIP). He is a past president of the South African Association of Hospital and Institutional Pharmacists (SAAHIP). At the FIP, he served as president of the Hospital Pharmacy Section, chairman of the Board of Pharmaceutical Practice, and vice president. He is currently a Director of the FIP Foundation for Education and Research.
He was appointed to the South African National Essential Medicines List Committee in 2013. He is currently chair of the Names and Scheduling Committee of the South African Health Products Regulatory Authority (SAHPRA) and serves on its Legal Committee and Pharmacovigilance Committee. He is a Member of the World Health Organization’s Expert Panel on Drug Policies and Management. He has served as a member, rapporteur and co-chairperson of the Expert Committee on the Selection and Use of Essential Medicines, as chairperson of the sub-committee on Essential Medicines for Children, on the WHO Guidelines Review Committee, and the WHO Guideline Steering Group for Family Planning Guidance.
Widely published, he has served as a reviewer for a number of international and local journals, is associate editor of the South African Pharmaceutical Journal, section editor of the Journal of Pharmaceutical Policy and Practice and serves on the editorial boards of the International Journal of Clinical Pharmacy, Health Systems and Reform, BMC Health Services Research and the Journal of Pharmaceutical Health Services Research. He has also been a member of the South African Health Review editorial committee. Andy has reviewed funding applications for several agencies, including the Health Systems Trust, National Research Foundation, Medical Research Council and UNITAID. He has been actively involved in the development and assessment of medicines and other health-related law in South Africa.
